Targeting Tyrosine kinases in Renal Cell Carcinoma: “New Bullets against Old Guys”
Clear cell renal cell carcinoma (ccRCC) is the seventh most frequently diagnosed tumor in adults in Europe and represents approximately 2.5% of cancer deaths. The molecular biology underlying renal cell carcinoma (RCC) development and progression has been a key milestone in the management of this ty...
Main Authors: | Teresa Alonso-Gordoa, María Laura García-Bermejo, Enrique Grande, Pilar Garrido, Alfredo Carrato, Javier Molina-Cerrillo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/8/1901 |
Similar Items
-
Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
by: Yumiko Tahira, et al.
Published: (2021-08-01) -
Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains
by: Adam Bajinting, et al.
Published: (2017-06-01) -
Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis
by: Feng Liu, et al.
Published: (2016-06-01) -
Mechanism and Therapeutic Potential of Statin-Mediated Inhibition of Tyrosine Kinase Receptors
by: Zhao, Tong Tong
Published: (2011) -
Mechanism and Therapeutic Potential of Statin-Mediated Inhibition of Tyrosine Kinase Receptors
by: Zhao, Tong Tong
Published: (2011)